中国药房2013，Vol.24Issue(24)：2224-2228,5.DOI:10.6039/j.issn.1001-0408.2013.24.05
我国基本药物价格水平实证研究
Empirical Study on Essential Medicine Price in China
管晓东 1李晗 2刘洋 1史录文1
作者信息
- 1. 北京大学药学院,北京 100191
- 2. 北京大学医药管理国际研究中心,北京100191
- 折叠
摘要
Abstract
OBJECTIVE:To evaluate the accessibility of essential medicine from the angle of medicine price.METHODS:Based on the improved WHO/HAI standardized approach,we investigated the price information of 30 medicines of different specifications in tertiary hospitals,primary health care facilities and retail pharmacies among eastern,central and western regions of China,and the MPR was compared by unification of active components.RESULTS:The MPR of 30 generic medicines varied from 0.79 to 68.59; hospitals in the central regions had the highest MPR and the pharmacies in the central regions had the lowest.The price level of generic medicines in third-grade class-A hospitals was relatively high,while that was relatively low in pharmacies.Original medicines had a very high price with the MPR of 35.6.There was a big price difference between original and generic medicines.CONCLUSIONS:The price level of generic medicines in eastern regions is higher than in central and western regions,and third-grade class-A hospitals is higher than primary health care facilities and retail pharmacies.The price level of generic medicine in China is either too low or too high,while there is no significant difference for the price level of original medicines among different regions.关键词
基本药物/WHO/HAI标准调查法/中位价格比/可及性Key words
Essential medicine/WHO/HAI standardized approach/MPR/Accessibility分类
医药卫生引用本文复制引用
管晓东,李晗,刘洋,史录文..我国基本药物价格水平实证研究[J].中国药房,2013,24(24):2224-2228,5.
